Lowe's Companies, Inc. : Should improve with a rebound
Entry price | Target | Stop-loss | Potential |
---|
US$46.73 |
US$0 |
US$45.3 |
-100% |
---|
Lowe’s health can be seen through its Surperformance ratings that bring to light its strong fundamentals. Moreover, perspective are encouraging, sales are expected to grow of 5% per year while net margin to improve of 18% by 2015. Furthermore, Thomson-Reuters analysts have revised upward their EPS and revenue estimations for the showing the good business dynamic. Finally, the share is supported by a strong buy consensus and a interesting potential when taking into account the average target price.
On a technical viewpoint, the stock evolves in a large channel of prices since it’s stopped a strong bullish trend. The last trading sessions have seen a consolidation movement that brought the share price back to an interesting level near USD 46.3. This level represent an opportune entry level as a rebound could happen, launching the stock to USD 49.
Therefore, a long position could be engaged at the current prices, the target will be USD 48.50 and by extension USD 49.5. A stop loss will be placed under the support level at USD 46.3 in case of a downward movement towards the bottom of the tunnel.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.